Furthermore, in human NASH liver biopsies, it has been shown that the promoter region of Pparγ undergoes methylation remodeling and becomes hypermethylated as fibrosis severity increases [44], indicating that DNA methylation may be used as a non-invasive tool for stratifying the risk of fibrosis in NAFLD. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.